Evidence map›Paper›PMID 22003419›Full record

ReviewAddiction science & clinical practice2011

Inhalant use and inhalant use disorders in the United States.

Matthew O Howard, Scott E Bowen, Eric L Garland, Brian E Perron, Michael G Vaughn

Open access · greenAbstract readReview
In one paragraph

Review in Addiction science & clinical practice, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 136 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Toluene Toxicity in the Brain: From Cellular Targets to Molecular Mechanisms.Annual review of pharmacology and toxicology · 2025
    Review
  8. Article
  9. Mucocutaneous Manifestations of Recreational Drug Use.American journal of clinical dermatology · 2024
    Review
  10. Predictors of self-reported general health status in people experiencing homelessness with serious mental illness.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Troponemia Secondary to Air Duster Inhalant Abuse.European journal of case reports in internal medicine · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Inhalant use in adolescents in northern Russia.Social psychiatry and psychiatric epidemiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Matthew O HowardUniversity of North Carolina, Chapel Hill, North Carolina 27599, USA. mohoward@email.unc.edu
Scott E Bowen
Eric L Garland
Brian E Perron
Michael G Vaughn
Social Welfare Department · HKUniversity of North Carolina at Chapel Hill · US

Funding

Behavioral Effects of Gestational Inhalant Abuse in RatsR01DA015951 · NIDA · WAYNE STATE UNIVERSITY · PI BOWEN, SCOTT E · 2002 to 2006
$1.7M
Natural History, Comorbid Mental Disorders, and Consequences of Inhalant AbuseR01DA021405 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOWARD, MATTHEW O · 2007 to 2009
$567k
Symptoms and Structure of Inhalant Use DisordersR03DA027832 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PERRON, BRIAN E · 2009 to 2010
$154k
NEUROPSYCHIATRIC IMPAIRMENT IN ADOLESCENT INHALANT USERSR03DA015929 · NIDA · WASHINGTON UNIVERSITY · PI HOWARD, MATTHEW O · 2002 to 2003
$153k
A Population-based Study of Emergency Room Care and Drug UseR03AA019575 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PERRON, BRIAN E · 2009 to 2010
$77k
NIAAA NIH HHS R03 AA019575NIDA NIH HHS DA021405NIDA NIH HHS DA15929NIDA NIH HHS DA15951NIDA NIH HHS R01 DA015951NIDA NIH HHS R01 DA021405NIDA NIH HHS R03 DA015929NIDA NIH HHS R03 DA027832
6 · The paper itself

Abstract

More than 22 million Americans age 12 and older have used inhalants, and every year more than 750,000 use inhalants for the first time. Despite the substantial prevalence and serious toxicities of inhalant use, it has been termed "the forgotten epidemic." Inhalant abuse remains the least-studied form of substance abuse, although research on its epidemiology, neurobiology, treatment, and prevention has accelerated in recent years. This review examines current findings in these areas, identifies gaps in the research and clinical literatures pertaining to inhalant use, and discusses future directions for inhalant-related research and practice efforts.

Indexed as

Biomedical ResearchEpidemiologic StudiesAge FactorsCognition DisordersHealth EducationHealth PromotionHumansInhalant AbuseMood DisordersNervous System DiseasesRisk FactorsSocioeconomic FactorsUnited States

Identifiers

PMID22003419
PMCPMC3188822
OpenAlexW52782739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.